Literature DB >> 7379332

Functional studies on purified eosinophils and neutrophils from patients with Schistosoma mansoni infections.

M A Vadas, J R David, A E Butterworth, V Houba, R F Sturrock, L David, R Herson, T A Siongok, R Kimani.   

Abstract

Unpurified peripheral blood leucocytes or purified eosinophils and neutrophils from patients with schistosomiasis and from normal individuals were compared for their ability to interact with antibody coated schistosomula of Schistosoma mansoni. There was no difference in the ability of buffy coat cells or neutrophils from patients and from normal individuals to mediate antibody-dependent 51Cr release from labelled schistosomula. However, eosinophils from patients were significantly better than those from normal individuals in causing antibody-dependent 51Cr release. This enhanced activity of eosinophils from patients with schistosomiasis was found to correlate with the intensity of their infection as judged by faecal egg counts. Eosinophils from patients also contained a higher proportion of cells with detectable Fc receptors than those from normal individuals. It is suggested that the difference in the behaviour of eosinophils from patients and from normals may reflect an 'activated' state of these cells in the infected individuals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7379332      PMCID: PMC1538115     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Passive transfer of acquired resistance to Schistosoma mansoni in laboratory mice.

Authors:  A Sher; S R Smithers; P Mackenzie
Journal:  Parasitology       Date:  1975-06       Impact factor: 3.234

3.  Studies on blood eosinophils. I. Patients with a transient eosinophilia.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

4.  Antibody-dependent cell-mediated damage to schistosomula in vitro.

Authors:  A E Butterworth; R F Sturrock; V Houba; P H Rees
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

5.  Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon.

Authors:  A A Mahmoud; R W Kellermeyer; K S Warren
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

6.  Rhodamine conjugates:specific and nonspecific binding properties in immunohistochemistry.

Authors:  P Brandtzaeg
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

7.  Morphological evidence for the ability of eosinophils to damage antibody-coated schistosomula.

Authors:  A M Glauert; A E Butterworth
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

8.  Schistosoma mansoni in the baboon (Papio anubis): parasitological responses of Kenyan baboons to different exposures of a local parasite strain.

Authors:  R F Sturrock; A E Butterworth; V Houba
Journal:  Parasitology       Date:  1976-12       Impact factor: 3.234

9.  The mechansim of antibody-dependent, eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro: a study by phase-contrast and electron microscopy.

Authors:  A M Glauert; A E Butterworth; R F Sturrock; V Houba
Journal:  J Cell Sci       Date:  1978-12       Impact factor: 5.285

10.  Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils.

Authors:  A E Butterworth; J R David; D Franks; A A Mahmoud; P H David; R F Sturrock; V Houba
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

View more
  9 in total

1.  Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes.

Authors:  V Rodrigues; K Piper; P Couissinier-Paris; O Bacelar; H Dessein; A J Dessein
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Authors:  Claus M Reimert; Colin M Fitzsimmons; Sarah Joseph; Joseph K Mwatha; Frances M Jones; Gachuhi Kimani; Karl F Hoffmann; Mark Booth; Narcis B Kabatereine; David W Dunne; Birgitte J Vennervald
Journal:  Clin Vaccine Immunol       Date:  2006-05

3.  Antibody-dependent cell-mediated effects in bancroftian filariasis.

Authors:  K Mehta; R K Sindhu; D Subrahmanyam; K Hopper; D S Nelson; C K Rao
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

4.  Parasite immunity and the major histocompatibility complex.

Authors:  M A Vadas
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

5.  Infection of mice with Nematospiroides dubius: demonstration of neutrophil-mediated immunity in vivo in the presence of antibodies.

Authors:  I A Penttila; P L Ey; C R Jenkin
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

6.  Bullous pemphigoid blister fluid stimulates eosinophil colony formation and activates eosinophils.

Authors:  G A Varigos; G Morstyn; M A Vadas
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

7.  Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.

Authors:  Lisa M Ganley-Leal; Pauline N Mwinzi; Catherine B Cetre-Sossah; Julius Andove; Allen W Hightower; Diana M S Karanja; Daniel G Colley; W Evan Secor
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

8.  Basis of the specificity of rodent trypanosomes for their natural hosts.

Authors:  J W Albright; J F Albright
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

Review 9.  Granulocytes in helminth infection -- who is calling the shots?

Authors:  B L Makepeace; C Martin; J D Turner; S Specht
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.